Adrian Felipe Hernandez, MD

Professor of Medicine
Duke Health Cardiology Professor
Vice Dean and Executive Director of Duke Clinical Research
Executive Core Faculty Member, Duke-Margolis Center for Health Policy
Member in the Duke Clinical Research Institute
Campus mail Duke Box 3850, Durham, NC 27710
Phone (919) 668-7515
Email address adrian.hernandez@duke.edu
In Their Words

Education and Training

  • Fellow in Cardiology, Medicine, Duke University, 2000 - 2004
  • Medical Resident, Medicine, University of California San Francisco, School of Medicine, 1997 - 2000
  • M.D., University of Texas at Dallas, 1997

Grants

Publications

DeVore, Adam D., Claude Larry Hill, Laine E. Thomas, Nancy M. Albert, Javed Butler, J Herbert Patterson, Adrian F. Hernandez, et al. “Identifying patients at increased risk for poor outcomes from heart failure with reduced ejection fraction: the PROMPT-HF risk model.” Esc Heart Fail 9, no. 1 (February 2022): 178–85. https://doi.org/10.1002/ehf2.13709.

PMID
34791838
Full Text

Franklin, Jessica M., Richard Platt, Nancy A. Dreyer, Alex John London, Gregory E. Simon, Jonathan H. Watanabe, Michael Horberg, Adrian Hernandez, and Robert M. Califf. “When Can Nonrandomized Studies Support Valid Inference Regarding Effectiveness or Safety of New Medical Treatments?” Clin Pharmacol Ther 111, no. 1 (January 2022): 108–15. https://doi.org/10.1002/cpt.2255.

PMID
33826756
Full Text

Simon, Gregory E., Richard Platt, Jonathan H. Watanabe, Andrew B. Bindman, Alex John London, Michael Horberg, Adrian Hernandez, and Robert M. Califf. “When Can We Rely on Real-World Evidence to Evaluate New Medical Treatments?” Clin Pharmacol Ther 111, no. 1 (January 2022): 30–34. https://doi.org/10.1002/cpt.2253.

PMID
33895994
Full Text

Simon, Gregory E., Andrew B. Bindman, Nancy A. Dreyer, Richard Platt, Jonathan H. Watanabe, Michael Horberg, Adrian Hernandez, and Robert M. Califf. “When Can We Trust Real-World Data To Evaluate New Medical Treatments?” Clin Pharmacol Ther 111, no. 1 (January 2022): 24–29. https://doi.org/10.1002/cpt.2252.

PMID
33932030
Full Text

Mann, Douglas L., Michael M. Givertz, Justin M. Vader, Randall C. Starling, Palak Shah, Steven E. McNulty, Kevin J. Anstrom, et al. “Effect of Treatment With Sacubitril/Valsartan in Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.” Jama Cardiol 7, no. 1 (January 1, 2022): 17–25. https://doi.org/10.1001/jamacardio.2021.4567.

PMID
34730769
Full Text

Watanabe, Jonathan H., Gregory E. Simon, Michael Horberg, Richard Platt, Adrian Hernandez, and Robert M. Califf. “When Are Treatment Blinding and Treatment Standardization Necessary in Real-World Clinical Trials?” Clin Pharmacol Ther 111, no. 1 (January 2022): 116–21. https://doi.org/10.1002/cpt.2256.

PMID
33829639
Full Text

Toro, Camilo, Sonia Jain, Shelly Sun, Nancy Temkin, Jason Barber, Geoffrey Manley, Jordan M. Komisarow, et al. “Association of Brain Injury Biomarkers and Circulatory Shock Following Moderate-Severe Traumatic Brain Injury: A TRACK-TBI Study.” J Neurosurg Anesthesiol, December 30, 2021. https://doi.org/10.1097/ANA.0000000000000828.

PMID
34967764
Full Text

McNally, Elizabeth M., Mitchell S. V. Elkind, Ivor J. Benjamin, Mina K. Chung, Glenn H. Dillon, Adrian F. Hernandez, Chinwe Ibeh, et al. “Impact of the COVID-19 Pandemic on Cardiovascular Science: Anticipating Problems and Potential Solutions: A Presidential Advisory From the American Heart Association.” Circulation 144, no. 23 (December 7, 2021): e461–71. https://doi.org/10.1161/CIR.0000000000001027.

PMID
34719260
Full Text

Samsky, Marc D., Robert J. Mentz, Amanda Stebbins, Yuliya Lokhnygina, Aaron W. Aday, Neha J. Pagidipati, W Schuyler Jones, et al. “Polyvascular disease and increased risk of cardiovascular events in patients with type 2 diabetes: Insights from the EXSCEL trial.” Atherosclerosis 338 (December 2021): 1–6. https://doi.org/10.1016/j.atherosclerosis.2021.10.011.

PMID
34741929
Full Text

Pages